CTLA4 and neoplasm: MHC-IIhi DCs was discovered in the tumors of Bifidobacterium-treated mice (40); orally feeding B. fragilis induced Th1 immune response in the tumor-draining lymph nodes and catalyzed the maturation of DCs in the TME, facilitating the restoration of the clinical response to CTLA-4 blockade (67).